sk&f 86466 has been researched along with Decerebrate Posturing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bock, C; Niederhoffer, N; Nordheim, U; Szabo, B | 1 |
| Ernsberger, P; Feinland, G; Gomez, RE; Reis, DJ | 1 |
2 other study(ies) available for sk&f 86466 and Decerebrate Posturing
| Article | Year |
|---|---|
Mechanism of the sympathoinhibition produced by the clonidine-like drugs rilmenidine and moxonidine.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Clonidine; Decerebrate State; Heart Rate; Imidazoles; Injections, Spinal; Medulla Oblongata; Microinjections; Oxazoles; Rabbits; Rilmenidine; Sympathetic Nervous System; Yohimbine | 1999 |
Rilmenidine lowers arterial pressure via imidazole receptors in brainstem C1 area.
Topics: Animals; Antihypertensive Agents; Benzazepines; Binding, Competitive; Blood Pressure; Brain Stem; Clonidine; Decerebrate State; Dose-Response Relationship, Drug; Heart Rate; Imidazoline Receptors; Male; Microinjections; Oxazoles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Drug; Rilmenidine | 1991 |